Evidence map›Paper›PMID 39574875›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Genetic Contributions to Alzheimer's Disease and Frontotemporal Dementia in Admixed Latin American Populations.

Juliana Acosta-Uribe, Stefanie D Piña Escudero, J Nicholas Cochran, Jared W Taylor, P Alejandra Castruita, Caroline Jonson, Erin A Barinaga, Kevin Roberts, Alexandra R Levine, Dawwod S George and 30 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

40 authors.

Juliana Acosta-UribeGrupo de Neurociencias de Antioquia (GNA), Facultad de Medicina, Universidad de Antioquia. Medellín, Colombia.
Stefanie D Piña EscuderoGlobal Brain Health Institute (GBHI), Department of Neurology, University of California San Francisco. San Francisco, USA.
J Nicholas CochranHudsonAlpha Institute for Biotechnology. Huntsville, USA.
Jared W TaylorHudsonAlpha Institute for Biotechnology. Huntsville, USA.
P Alejandra CastruitaMemory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco. San Francisco, USA.
Caroline JonsonMemory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco. San Francisco, USA.
Erin A BarinagaHudsonAlpha Institute for Biotechnology. Huntsville, USA.
Kevin RobertsHudsonAlpha Institute for Biotechnology. Huntsville, USA.
Alexandra R LevineNeuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California Santa Barbara. Santa Barbara, USA.
Dawwod S GeorgeNeuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California Santa Barbara. Santa Barbara, USA.
José Alberto ÁvilaFunesInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Ciudad de México, México.
María I BehrensDepartamento de Neurología y Psiquiatría, Clínica Alemana-Universidad del Desarrollo. Santiago, Chile.
Martín A BrunoInstituto de Ciencias Biomédicas (ICBM) Facultad de Ciencias Médicas, Universidad Católica de Cuyo. San Juan, Argentina.
Luis I BruscoAsociación Alzheimer Argentina (ALZAR). Buenos Aires, Argentina.
Nilton CustodioInstituto Peruano de Neurociencias. Lima, Perú.
Claudia Duran-AniotzLatin American Institute for Brain Health (BrainLat), Universidad Adolfo Ibanez. Santiago, Chile.
Francisco LoperaGrupo de Neurociencias de Antioquia (GNA), Facultad de Medicina, Universidad de Antioquia. Medellín, Colombia.
Diana L MatallanaInstituto de Envejecimiento, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia.
Andrea SlachevskyDepartamento de Neurología y Psiquiatría, Clínica Alemana-Universidad del Desarrollo. Santiago, Chile.
Leonel T TakadaHospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo. São Paulo, Brasil.
Lina M Zapata-RestrepoFacultad de Ciencias de la Salud, Universidad Icesi. Cali, Colombia.
Dafne E Durón-ReyesInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Ciudad de México, México.
Elisa de Paula França ResendeGlobal Brain Health Institute (GBHI), Department of Neurology, University of California San Francisco. San Francisco, USA.
Nancy GelvezInstituto de genética humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia.
Maria E GodoyLatin American Institute for Brain Health (BrainLat), Universidad Adolfo Ibanez. Santiago, Chile.
Marcelo A MaitoLatin American Institute for Brain Health (BrainLat), Universidad Adolfo Ibanez. Santiago, Chile.
Shireen JavandelGlobal Brain Health Institute (GBHI), Department of Neurology, University of California San Francisco. San Francisco, USA.
Bruce L MillerGlobal Brain Health Institute (GBHI), Department of Neurology, University of California San Francisco. San Francisco, USA.
Mike A NallsDataTecnica LLC, Washington DC, USA.
Hampton LeonardDataTecnica LLC, Washington DC, USA.
Dan VitaleDataTecnica LLC, Washington DC, USA.
Sara Bandres-CigaCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health. Bethesda, USA.
Mathew J KoretskyDataTecnica LLC, Washington DC, USA.
Andrew B SingletonCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health. Bethesda, USA.
Caroline B PantazisCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health. Bethesda, USA.
Victor ValcourGlobal Brain Health Institute (GBHI), Department of Neurology, University of California San Francisco. San Francisco, USA.
Agustin IbañezLatin American Institute for Brain Health (BrainLat), Universidad Adolfo Ibanez. Santiago, Chile.
Kenneth S KosikNeuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California Santa Barbara. Santa Barbara, USA.
Jennifer S YokoyamaGlobal Brain Health Institute (GBHI), Department of Neurology, University of California San Francisco. San Francisco, USA.
Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat)

Funding

Harmonized Data-Derived Resources for the Alzheimer's Disease and Related Dementias CommunityZIAAG000534 · NIA · NATIONAL INSTITUTE ON AGING · PI COOKSON, MARK · 2019 to 2025
$85.1M
TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
Project 2: Biomarker Analysis, Non-Genetic Risk Factors, and Their Genetic InteractionsU19AG079774 · NIA · UNIVERSITY OF PENNSYLVANIA · PI HELENA Chang CHUI, Gyungah Jun · 2023 to 2026
$39.4M
Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Katherine P Rankin · 2019 to 2026
$36.9M
Tau Metabolism in FTD: From Gene Mutations to Molecular Chaperones and Lysosomal ProteasesU54NS123985 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AGARD, DAVID A., KAO, AIMEE · 2021 to 2025
$9.0M
An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populationsR01AG075775 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARIA LUISA GORNO TEMPINI, Adolfo Martin Garcia · 2023 to 2026
$7.2M
Molecular Basis of the Tau Aggregation PathwayR01AG056058 · NIA · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI Songi Han, KENNETH Stephen KOSIK · 2017 to 2026
$6.4M
US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative ResearchR01AG057234 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Claudia Duran-Aniotz, Agustin M. Ibanez · 2019 to 2026
$6.1M
Elucidating clinical heterogeneity in early-onset AD via genomics, transcriptomics, and neuroimagingR01AG062588 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YOKOYAMA, JENNIFER S · 2019 to 2023
$4.0M
Social epigenetics of Alzheimer's disease and related dementias in Latin American countriesR01AG082056 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Michael Jay Corley · 2024 to 2026
$3.6M
Circadian Disturbance and Dementia in Latin AmericaR01AG083799 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Kun Hu, Agustin M. Ibanez · 2023 to 2026
$3.0M
Intramural NIH HHS ZIA AG000534NIA NIH HHS P01 AG019724NIA NIH HHS P30 AG062422NIA NIH HHS R01 AG056058NIA NIH HHS R01 AG057234NIA NIH HHS R01 AG062588NIA NIH HHS R01 AG075775NIA NIH HHS R01 AG082056NIA NIH HHS R01 AG083799NIA NIH HHS U19 AG079774NIDA NIH HHS 75N95022C00031NINDS NIH HHS U54 NS123985
6 · The paper itself

Abstract

Background: Latin America's diverse genetic makeup, shaped by centuries of admixture, presents a unique opportunity to study Alzheimer's disease dementia (AD) and frontotemporal dementia (FTD). Our aim is to identify genetic variations associated with AD and FTD within this population. Methods: The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat) recruited 2,162 participants with AD, FTD, and healthy controls from six Latin American countries (Argentina, Brazil, Chile, Colombia, Mexico, and Peru). All participants underwent array, exome, and/or whole-genome sequencing. Population structure was analyzed using Principal Component Analysis and ADMIXTURE, projecting the ReDLat population onto the 1000 Genomes Project database. To identify genes associated with autosomal dominant, autosomal recessive, or X-linked forms of adult-onset dementia, we searched the Online Mendelian Inheritance in Man database and analyzed pedigree information. Variant interpretation followed guidelines from the American College of Medical Genetics and Genomics, and the Guerreiro algorithm was applied for the Results: Global ancestry analysis of the ReDLat cohort revealed a predominant mix of American, African, and European ancestries. Uniquely, Brazil displayed an additional East Asian component accurately reflecting the historical admixture patterns from this region. We identified 17 pathogenic variants, a pathogenic Conclusions: This study provides the first snapshot of genetic contributors to AD and FTD in a multisite cohort across Latin America. It will be critical to evaluate the generalizability of genetic risk factors for AD and FTD across diverse ancestral backgrounds, considering distinct social determinants of health and accounting for modifiable risk factors that may influence disease risk and resilience across different cultures.

Indexed as

AdmixtureAlzheimer’s diseaseAutosomal dominant dementiaFrontotemporal dementiaLatin AmericaNeurodegeneration

Identifiers

PMID39574875
PMCPMC11581085

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.